WO2026138971 - PHARMACEUTICAL USE OF COMPOUND A OR SALT THEREOF
National phase entry is expected:
Publication Number
WO/2026/138971
Publication Date
02.07.2026
International Application No.
PCT/CN2025/145649
International Filing Date
25.12.2025
Title **
[English]
PHARMACEUTICAL USE OF COMPOUND A OR SALT THEREOF
[French]
UTILISATION PHARMACEUTIQUE D'UN COMPOSÉ A OU D'UN SEL DE CELUI-CI
[Chinese]
一种化合物A或其盐的医药用途
Applicants **
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD
Inventors
XIAO, Ying
LI, Hongchao
XING, Wei
LU, Yinsuo
YANG, Zhao
XING, Yan
Priority Data
PCT/CN2024/142727
26.12.2024
CN
202510864389.2
25.06.2025
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1635 | |
| EPO | Filing, Examination, Granting | 11708 | |
| Japan | Filing, Examination, Granting | 2002 | |
| South Korea | Filing, Examination, Granting | 1722 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
21,807
Contact Us
Abstract[English]
The present invention relates to the technical field of chemical drugs, provides a pharmaceutical use of compound A or a salt thereof, and specifically relates to a use of compound A or the salt thereof in preparation of a drug for preventing or treating heart failure (HF)-related diseases.[French]
La présente invention relève du domaine technique des médicaments chimiques, et concerne une utilisation pharmaceutique du composé A ou d'un sel de celui-ci, et plus particulièrement une utilisation du composé A ou du sel de celui-ci dans la préparation d'un médicament pour la prévention ou le traitement de maladies associées à l'insuffisance cardiaque (HF).[Chinese]
本发明属于化学药物技术领域，提供了一种化合物A或其盐的医药用途，具体涉及一种化合物A或其盐在制备用于预防或治疗与心衰(HF)相关疾病的药物中的用途。